ReachMD

Be part of the knowledge.™

Medical Industry Feature

Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.

354

LikeLikedUnlike

Episodes 151-165 of 173

Understanding PMR Pathophysiology: An Expert's Perspective
Medical Industry Feature
Understanding PMR Pathophysiology: An Expert's Perspective
- Leonard H. Calabrese, DO
  Peer
Gout Epidemiology and Pathogenesis
Living Rheum
Gout Epidemiology and Pathogenesis
- Jason Liebowitz, MD
  Peer
- Sara Tedeschi, MD, MPH
  Peer
Understanding the Evolving Role of Biosimilars in Gastroenterology
Medical Industry Feature
Understanding the Evolving Role of Biosimilars in Gastroenterology
- Jennifer Caudle, DO
  Peer
- Stephen Hanauer, MD
  Peer
MSperceptions: Candid HCP/Patient Clinical Conversations about MS
Medical Industry Feature
MSperceptions: Candid HCP/Patient Clinical Conversations about MS
- Jacqueline Nicholas, MD, MPH
  Peer
- Barry A. Singer, MD
  Peer
Assessing PsA Disease Activity in Clinical Practice
Living Rheum
Assessing PsA Disease Activity in Clinical Practice
- Ethan Craig, MD, MHS
  Peer
- Alexis Ogdie, MD, MSCE
  Peer
Diagnosing and Identifying Patients With von Hippel-Lindau (VHL) Disease
Medical Industry Feature
Diagnosing and Identifying Patients With von Hippel-Lindau (VHL) Disease
- Wendy Chung, MD
  Peer
CPPD Epidemiology and Pathogenesis
Living Rheum
CPPD Epidemiology and Pathogenesis
- Jason Liebowitz, MD
  Peer
- Sara Tedeschi, MD, MPH
  Peer
Exploring Key Clinical Trial Results for Adults With T2D
Medical Industry Feature
Exploring Key Clinical Trial Results for Adults With T2D
- A'Niyah Birdsong
  Peer
- Eden Miller, DO*
  Peer
- James R. Gavin III, MD, PhD*
  Peer
Gene Therapy in SMA Care
Medical Industry Feature
Gene Therapy in SMA Care
- Jennifer Caudle, DO
  Peer
- Sandra P. Reyna, MD
  Peer
Persistent Fluid in Wet Age-related Macular Degeneration: Understanding the Disease Pathophysiology
Medical Industry Feature
Persistent Fluid in Wet Age-related Macular Degeneration: Understanding the Disease Pathophysiology
- John Kitchens, MD
  Peer
- W. Lloyd Clark, MD
  Peer
- Szilard Kiss, MD
  Peer
Evolution in the Treatment of Newly Diagnosed, Transplant-Ineligible Patients With Multiple Myeloma
Medical Industry Feature
Evolution in the Treatment of Newly Diagnosed, Transplant-Ineligible Patients With Multiple Myeloma
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Ruemu Birhiray, MD
  Peer
- Shebli Atrash, MD
  Peer
Type 2 Diabetes & ASCVD: Cardiovascular Risk Reduction According to the Guidelines
Heart Matters
Type 2 Diabetes & ASCVD: Cardiovascular Risk Reduction According to the Guidelines
- Matthew Jay Budoff, MD
  Peer
Evaluating Urolithin A Supplementation on Muscle Endurance & Mitochondrial Health
Medical Industry Feature
Evaluating Urolithin A Supplementation on Muscle Endurance & Mitochondrial Health
- Anurag Singh, MD, PhD
  Peer
Understanding Urolithin A: Impacts of Supplementation on Muscle Strength & Exercise Performance
Medical Industry Feature
Understanding Urolithin A: Impacts of Supplementation on Muscle Strength & Exercise Performance
- Chris Rinsch, PhD
  Peer
Cardiovascular Risk Reduction for Adults With Type 2 Diabetes & ASCVD: A Collaborative Approach
Heart Matters
Cardiovascular Risk Reduction for Adults With Type 2 Diabetes & ASCVD: A Collaborative Approach
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Matthew Jay Budoff, MD
  Peer
- Joshua Stolker, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended